{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-107429","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2026-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.177859+00:00","generated_at":"2026-05-15T11:34:55.778721+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Soleno amends bylaws with advance notice changes, forum selection, governance updates","bullets":["Board approved Amended and Restated Bylaws effective March 16, 2026.","Updated advance notice provisions for stockholder proposals and director nominations.","Amendments reflect recent Delaware law changes and include a forum selection clause.","Certain governance updates and technical/clarifying changes were also made."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-107429","json":"https://secwatch.observer/filing/0001193125-26-107429.json","markdown":"https://secwatch.observer/filing/0001193125-26-107429.md","text":"https://secwatch.observer/filing/0001193125-26-107429.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312526107429/0001193125-26-107429-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312526107429/d107502d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T11:34:55.778721+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27e25af2181501e3b9d03ea68491a0b4765efccb","claim":"SOLENO THERAPEUTICS INC: Amended and Restated Bylaws to update advance notice provisions, reflect Delaware law changes, make governance updates, and include a forum selection provision (effective 2026-03-16).","evidence_excerpt":"On March 16, 2026, the Board of Directors (the “Board”) of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, approved and adopted the Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), effective as of such date.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484565/000119312526107429/0001193125-26-107429-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2026-03-16"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}